Tell the Congress: The FDA's Draft Guidance on NDIs is Bad for Consumers

Spread the word with EmailFacebookTwitter
Share on Facebook
Cancel
Share on MySpace
Cancel
Share on Twitter
A short URL will be added to the end of your Tweet.

Cancel
Share on LinkedIn
Cancel

On July 1, the US Food and Drug Administration issued draft guidance for complying with the New Dietary Ingredient (NDI) notification protocols required by the Dietary Supplement Health and Education Act (DSHEA)—seventeen years late.

The biggest problem is that this guidance will turn a notification system into an approval system—a terrible precedent that will utterly cut off the supply of nutritional supplements. It will also create such huge barriers for supplement manufacturers that it will be much more difficult and expensive to produce them. But of course, that means consumers would either have to pay much more for nutritional supplements, or else risk not being able to buy them at all if the manufacturer deems them too expensive to produce.

(Please personalize your message if you have the time!)

Recipients

  • President Barack Obama
  • Your Senators
  • Your Representative

Contact

*Required fields
 
 

Message

Dear Representative,

Sincerely,
[Your Name]
[Your Address]
[City, State ZIP]